# Optimal Dose of Intravenous Oxycodone for Endotracheal Intubation

> **NCT02484352** · PHASE4 · COMPLETED · sponsor: **Yong-Hee Park** · enrollment: 95 (actual)

## Conditions studied

- Intubation Complication
- Blood Pressure

## Interventions

- **DRUG:** saline
- **DRUG:** 0.05 mg/kg of oxycodone
- **DRUG:** 0.1 mg/kg of oxycodone
- **DRUG:** 0.15 mg/kg of oxycodone
- **DRUG:** 0.2 mg/kg of oxycodone

## Key facts

- **NCT ID:** NCT02484352
- **Lead sponsor:** Yong-Hee Park
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2015-10
- **Final completion:** 2017-02-12
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2017-07-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02484352

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02484352, "Optimal Dose of Intravenous Oxycodone for Endotracheal Intubation". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02484352. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*